Hepatocellular carcinoma and musculoskeletal system: A narrative literature review

doi:10.3748/wjg.v30.i15.2109

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 30, Issue 15

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2349)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series.

Item

Count

PDF

HTML

1678

Figures (1-2)

228

Sum=1963

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

232

Sum=300

Apr 21, 2024 (publication date) through Nov 20, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastroenterol. Apr 21, 2024; 30(15): 2109-2117
Published online Apr 21, 2024. doi: 10.3748/wjg.v30.i15.2109

Hepatocellular carcinoma and musculoskeletal system: A narrative literature review

Jelena Jadzic, Danijela Djonic

Jelena Jadzic, Danijela Djonic, Center of Bone Biology, Faculty of Medicine, University of Belgrade, Belgrade 11000, Serbia

Author contributions: Jadzic J conceptualized the study, wrote the initial draft, and conducted the visualization; Jadzic J and Djonic D acquired the data; Djonic D reviewed and edited the manuscript; and all authors read and approved the final version of the manuscript.

Supported by the Ministry of Science of the Republic of Serbia, No. 451-03-1524/2023-04/18; and the Science Fund of the Republic of Serbia (IDEAS Program), No. 7749444, BoFraM Project.

Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Danijela Djonic, MD, PhD, Professor, Center of Bone Biology, Faculty of Medicine, University of Belgrade, Dr. Subotic 4/2, Belgrade 11000, Serbia. ddjonic@yahoo.com

Received: January 4, 2024
Peer-review started: January 4, 2024
First decision: January 27, 2024
Revised: February 7, 2024
Accepted: March 26, 2024
Article in press: March 26, 2024
Published online: April 21, 2024
Processing time: 105 Days and 21.8 Hours

Core Tip

Core Tip: Musculoskeletal alterations have a powerful detrimental effect on the quality of life and prognosis of patients with hepatocellular carcinoma (HCC). The causes of HCC-induced musculoskeletal decline are complex and not yet fully understood. The biggest challenge in diagnosing HCC-related musculoskeletal changes is timely and effective diagnosis, as these alterations are often asymptomatic and may not be obvious during routine clinical evaluations. Therefore, a multidisciplinary approach to the clinical management of musculoskeletal alterations is essential in patients with HCC.